4 results on '"Xu, Yuan Wen"'
Search Results
2. Dairy Product Consumption and Bladder Cancer Risk: A Meta-Analysis.
- Author
-
Wu, Jianhua, Yu, Yi, Huang, Liqi, Li, Zirui, Guo, Penghui, and Xu, Yuan Wen
- Subjects
BLADDER tumors ,DAIRY products ,META-analysis ,MILK ,RISK assessment ,SYSTEMATIC reviews ,RELATIVE medical risk ,DISEASE risk factors - Abstract
To explore the potential relationship between dairy product consumption and bladder cancer risk, we retrieved eligible studies published up to March 15, 2018, via online database search and manual review of the selected articles. Summary relative risk (RR) estimates were calculated using random-effects models based on high to low intake values. Inter-study heterogeneity was explored using stratified analyses of study design, geographic region, or whether studies adjusted for the confounders age, sex, body mass index, smoking, and education level. We extracted data from 16 studies on milk (5,193 subjects) and 10 studies on dairy products (20,434 subjects). The total study population included 220,952 individuals. Dairy product intake and bladder cancer risk were significantly associated, and milk intake and bladder cancer risk more so. Stratified analysis revealed that the trend was more pronounced in case–control studies, and in studies with impact factor <3 and in Asia. The relationship was confirmed after adjusting for sex and Newcastle–Ottawa Scale score of 7 and 8. Our study shows an inverse association between milk consumption and bladder cancer risk. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population.
- Author
-
Liu XL, Pan Q, Zhang RN, Shen F, Yan SY, Sun C, Xu ZJ, Chen YW, and Fan JG
- Subjects
- Adult, Alanine Transaminase blood, Area Under Curve, Asian People genetics, Aspartate Aminotransferases blood, Biopsy, Case-Control Studies, China epidemiology, Female, Genetic Markers, Hepatitis B, Chronic blood, Hepatitis B, Chronic diagnosis, Hepatitis B, Chronic ethnology, Humans, Keratin-18 blood, Liver Cirrhosis blood, Liver Cirrhosis diagnosis, Liver Cirrhosis ethnology, Liver Cirrhosis genetics, Male, MicroRNAs blood, Middle Aged, Non-alcoholic Fatty Liver Disease blood, Non-alcoholic Fatty Liver Disease diagnosis, Non-alcoholic Fatty Liver Disease ethnology, Platelet Count, Predictive Value of Tests, ROC Curve, Hepatitis B, Chronic genetics, MicroRNAs genetics, Non-alcoholic Fatty Liver Disease genetics
- Abstract
Aim: To assess disease-specific circulating microRNAs (miRNAs) in non-alcoholic steatohepatitis (NASH) patients., Methods: A total of 111 biopsy-proven non-alcoholic fatty liver disease (NAFLD) or chronic hepatitis B (CHB) patients and healthy controls from mainland China were enrolled to measure their serum levels of miR-122, -125b, -146b, -16, -21, -192, -27b and -34a. The correlations between serum miRNAs and histological features of NAFLD were determined. The diagnostic value of miRNA in NASH and significant fibrosis was analyzed and compared with that of cytokeratin-18 (CK-18), fibrosis-4 (FIB-4), and aspartate aminotransferase to platelet ratio index (APRI), respectively., Results: Circulating miR-122, -16, -192 and -34a showed differential expression levels between NAFLD and CHB patients, and miR-34a had an approximately 2-fold increase in NAFLD samples compared with that of CHB samples ( P < 0.01). Serum miR-122, -192 and -34a levels were correlated with steatosis (R = 0.302, 0.323 and 0.470, respectively, P < 0.05) and inflammatory activity (R = 0.445, 0.447 and 0.517, respectively, P < 0.01); only serum miR-16 levels were associated with fibrosis (R = 0.350, P < 0.05) in patients with NAFLD. The diagnostic value of miR-34a for NASH (area under the receiver operating characteristic, 0.811, 95%CI: 0.670-0.953) was superior to that of alanine aminotransferase, CK-18, FIB-4 and APRI in NAFLD, but miR-16 showed a limited performance in the diagnosis of significant fibrosis in NASH., Conclusion: Circulating miR-34a may serve as a disease-specific noninvasive biomarker for the diagnosis of NASH., Competing Interests: Conflict-of-interest statement: The authors declare that they have no conflict of interest.
- Published
- 2016
- Full Text
- View/download PDF
4. [Clinical study on Shen Shuai Fang in treating chronic renal failure].
- Author
-
Wu XL, Li ZJ, Zhang WJ, Ao QX, and Xu YW
- Subjects
- Adolescent, Adult, Aged, Drug Combinations, Female, Humans, Kidney Failure, Chronic pathology, Kidney Function Tests, Male, Middle Aged, Ramipril therapeutic use, Treatment Outcome, Yin Deficiency drug therapy, Young Adult, Drugs, Chinese Herbal therapeutic use, Kidney Failure, Chronic drug therapy, Phytotherapy, Plants, Medicinal chemistry
- Abstract
Objective: To explore the effect of Shen Shuai Fang in treating Chronic Renal Failure (CRF) of deficiency of spleen and kidney with turbid damp and blood stagnation symptom., Methods: 125 patients with CRF of deficiency of spleen and kidney with turbid damp and blood stagnation symptom were randomly divided into two groups, 75 patients in treatment group were treated with Shen Shuai Fang adding western medicine and the other patients in control group were treated only with western medicine. We observed the effect and indexes change including renal function, Hb, proteinuria, lipid before and after treatment., Results: After six months' treatment, the general effective rate in treatment group was 77.33%, which was higher than that in control group obviously (44.00%, P < 0.01). So treatment group was obviously better than control group on decreasing proteinuria, improving renal function, increasing Hb, ameliorating lipid metabolism (P < 0.05 or P < 0.01)., Conclusion: Shen Shuai Fang is effective to treat CRF of deficiency of spleen and kidney with turbid damp and blood stagnation symptom.
- Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.